Use of 2,5-dihydroxybenzenesulphonic acid in the production of medicaments for the treatment of angiodependent diseases such as cancer and psoriasis

Details for Australian Patent Application No. 2005211956 (hide)

Owner Action Medicines, S.L.

Inventors Valverde Lopez, Serafin; Romero Garrido, Antonio; Gimenez Gallego, Guillermo; Cuevas Sanchez, Pedro; Lozano Puerto, Rosa Maria

Agent Davies Collison Cave

Pub. Number AU-B-2005211956

PCT Pub. Number WO2005/077352

Priority P200400371 17.02.04 ES

Filing date 16 February 2005

Wipo publication date 25 August 2005

Acceptance publication date 28 July 2011

International Classifications

A61P 35/00 (2006.01) Antineoplastic agents

A61K 31/185 (2006.01) - Acids

A61K 31/255 (2006.01)

A61P 17/06 (2006.01) Drugs for dermatological disorders

Event Publications

31 August 2006 PCT application entered the National Phase

  PCT publication WO2005/077352 Priority application(s): WO2005/077352

28 July 2011 Application Accepted

  Published as AU-B-2005211956

24 November 2011 Standard Patent Sealed

16 February 2012 Assignment Registered

  Action Medicines, S.L. The patent has been assigned to AmDerma Pharmaceuticals, LLC

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005211958-Method for enhancing the bioavailability of ospemifene

2005211955-Use of non-peptidic NK1 receptor antagonists for the production of apoptosis in tumour cells